Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002901180 | SCV003641452 | uncertain significance | Inborn genetic diseases | 2022-09-14 | criteria provided, single submitter | clinical testing | The c.8597A>C (p.E2866A) alteration is located in exon 38 (coding exon 38) of the KMT2C gene. This alteration results from a A to C substitution at nucleotide position 8597, causing the glutamic acid (E) at amino acid position 2866 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |